Skip to main content
. 2010 Nov 3;9:37. doi: 10.1186/1744-859X-9-37

Figure 2.

Figure 2

Effects of subchronic treatments with etizolam and ethyl loflazepate on P300. *P < 0.05 compared to pretreatment (repeated analysis of variance (ANOVA)).

HHS Vulnerability Disclosure